Klinik Löwenstein gGmbH
Industry / private company
Location:
Löwenstein,
Germany (DE)
ISNI: 0000 0004 0559 5672
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung) (2021)
Heudobler D, Schulz C, Fischer JR, Staib P, Wehler T, Suedhoff T, Schichtl T, et al.
Journal article
Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry (2020)
Kaemmerer H, Gorenflo M, Huscher D, Pittrow D, Apitz C, Baumgartner H, Berger F, et al.
Journal article
Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling (2017)
Belharazem D, Grass A, Paul C, Vitacolonna M, Schalke B, Rieker R, Koerner D, et al.
Journal article